Spain-based solar energy firm X-Elio said on Tuesday that it has signed a multi-buyer power purchase agreement (PPA) with biotechnology and pharmaceutical companies Thermo Fisher Scientific Inc (<a href="https://www.nyse.com/quote/XNYS:TMO" target="_blank">NYSE:TMO</a>), Haleon Plc (<a href="https://www.londonstockexchange.com/stock/HLN/haleon-plc/company-page" target="_blank">LON:HLN</a>), Gilead Sciences Inc (<a href="https://www.nasdaq.com/market-activity/stocks/gild" target="_blank">NASDAQ:GILD</a>), and GSK Plc (<a href="https://www.londonstockexchange.com/stock/GSK/gsk-plc/company-page" target="_blank">LON:GSK</a>) to supply 245 GWh of clean electricity annually for ten years.
Jun 9, 2026
BrusselsJun 22, 2026MunichJun 9, 2026BrusselsJun 22, 2026Munich
